- R&D Pipeline
- Season 2 (2021-2030)
| Modality | Indication | Targets | Stage | Company | Project No. | Detail | |
|---|---|---|---|---|---|---|---|
| 1 | The lead selection study of TLR2 targeted antisense oligonucleotide using PNA as a therapeutic agent for Parkinson’s Disease (PD) | ||||||
| Nucleic acid/Virus | Parkinson's Disease | TLR2 | Lead | SEASUN THERAPEUTICS, Inc. | HN22C0411 | ||
| 2 | Discovery of a lead compound utilizing exon skipping platform for the treatment of amyotrophic lateral sclerosis | ||||||
| Nucleic acid/Virus | Amyotrophic Lateral Sclerosis | STMN2 | Lead | OliPass corporation | HN22C0017 | ||